Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

特罗凯 - NMPA Drug Approval Details

Approvals/NMPA/Erlotinib Hydrochloride Tablets

Approved

化学药品

Erlotinib Hydrochloride Tablets

Roche Registration GmbH🇨🇳 National Medical Products Administration

Approval Date: Oct 20, 2025
Approval ID: 8885HmQFTAs
Company: Roche Registration GmbH
Type: 化学药品

Approval Details

Approval Id: 8885HmQFTAs
Approval Number: 国药准字HJ20160392
Generic Name: 盐酸厄洛替尼片
Generic Name En: Erlotinib Hydrochloride Tablets
Trade Name: 特罗凯
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 100mg
Reg Date: 2025-10-20
Expired Date: 2030-10-19
Company Name: Roche Registration GmbH
Production Company Name: DELPHARM MILANO SRL
Company Detail Path: /organization/roche-registration-gmbh
Production Company Detail Path: /organization/delpharm-milano-srl

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 20, 2025

Approval ID

8885HmQFTAs

Type

化学药品

Back to NMPA Approvals